Citigroup’s Sophiris Bio, Inc. SPHS Stock Holding History

Citigroup’s Portfolio SPHS Stock Details SPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,000	Closed	-$1K	–	7932
2016 Q1	$1K	Hold	1,000	–	–	﹤0.01%	7406
2015 Q4	$2K	Sell	1,000 -53	-5%	-$78	﹤0.01%	7344
2015 Q3	$1K	Sell	1,053 -1,185	-53%	-$1.03K	﹤0.01%	7323
2015 Q2	$2K	Buy	2,238 +1,238	+124%	+$1.05K	﹤0.01%	7242
2015 Q1	$1K	Sell	1,000 -4,150	-81%	-$2.22K	﹤0.01%	7156
2014 Q4	$3K	Buy	5,150 +4,119	+400%	+$9.56K	﹤0.01%	6835
2014 Q3	$3K	Buy	+1,031	New	+$2.9K	﹤0.01%	6777
2014 Q2	–	Sell	-588	Closed	-$2K	–	7663
2014 Q1	$2K	Buy	588 +479	+439%	+$1.88K	﹤0.01%	6837
2013 Q4	$0	Hold	109	–	–	﹤0.01%	7489
2013 Q3	$0	Buy	+109	New	+$502	﹤0.01%	7314

Other funds holding SPHS

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Airain Ltd St. Peter Port, Guernsey $2.26B AUM 12.43% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Citigroup's SPHS Position: Q2 2016 in Review

Citigroup sold out of Sophiris Bio, Inc. (SPHS) in Q2 2016, closing a stake of 1,000 shares — an estimated $1K sold.

Citigroup first reported a position in SPHS in Q3 2013 and held it in 10 quarters. The position peaked at $3K in Q4 2014. 19 funds tracked by Wall St. Rank hold SPHS as of Q2 2016.

Citigroup reported no remaining Sophiris Bio, Inc. position as of Q2 2016 after selling out during the quarter.
Citigroup sold 1,000 Sophiris Bio, Inc. shares in Q2 2016, an estimated $1K.
Citigroup first reported a position in Sophiris Bio, Inc. in Q3 2013 and held it in 10 quarters.
Citigroup's Sophiris Bio, Inc. position peaked at $3K in Q4 2014.
19 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q2 2016.

Based on Citigroup's 13F filing for Q2 2016, filed 12 Aug 2016.